Advertisement
Advertisement

NRIX

NRIX logo

Nurix Therapeutics, Inc. Common stock

10.24
USD
+0.44
+4.51%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

10.06

-0.18
-1.77%

Nurix Therapeutics, Inc. Common stock Profile

About

Nurix Therapeutics Inc.is a biopharmaceutical company. It focuses on the discovery, development and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company's product candidates include NX-2127 and NX-1607 which are in clinical stage. Nurix Therapeutics Inc.is based in San Francisco, California.

Info & Links

CEO

Arthur T. Sands

Headquarters

1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.nurixtx.com

Auditor

PricewaterhouseCoopers LLP

Share holders

8

Employees

286

Nurix Therapeutics, Inc. Common stock Statistics

Valuation Measures

Market Capitalization2

767.01M

Enterprise Value

691.09M

Enterprise Value/EBITDA(ttm)

-3.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

23.71

Price to Book(mrq)

2.29

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-354.85%

Profit Margin(ttm)

-375.86%

Return on Equity(ttm)

-53.65%

Return on Invested Capital(ttm)

-47.83%

Return on Assets(ttm)

-38.59%

Income Statement

Revenue(ttm)

56.42M

Revenue Per Share(ttm)

0.74

Gross Profit(ttm)

56.42M

EBITDA(ttm)3

-225.29M

Net Income Available to Common(ttm)

-208.40M

Diluted EPS(ttm)

-2.89

Share Statistics

Beta (5Y Monthly)

2.14

52-Week Change

-29.07%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

76.24M

Dividend Yield

0.00%

Float4

70.42M

% Held by Insiders

7.20%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

549.68M

Total Cash Per Share(mrq)

7.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.26%

Quick Ratio(mrq)

6.46%

Book Value Per Share(mrq)

6.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-64.57M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement